Digitoxigenin
97%
- Product Code: 97367
CAS:
143-62-4
| Molecular Weight: | 374.52 g./mol | Molecular Formula: | C₂₃H₃₄O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00003687 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
Digitoxigenin is primarily used in the field of pharmacology and medical research due to its role as a precursor in the synthesis of cardiac glycosides, such as digoxin and digitoxin. These compounds are crucial in the treatment of various heart conditions, including atrial fibrillation, atrial flutter, and heart failure. Digitoxigenin itself exhibits cardiotonic properties, which help in enhancing the force of heart contractions and improving cardiac output. Additionally, it is employed in biochemical studies to investigate the mechanisms of action of cardiac glycosides and their effects on sodium-potassium ATPase activity. Its application extends to the development of new therapeutic agents targeting cardiovascular diseases.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Almost white powder to crystal |
| PURITY | 96.5-100 |
| Infrared spectrum | Conforms to Structure |
| Specific rotation a20DC1 MeOH | 15.0 +20.0 |
| Lambda max.EtOH50 | 218.0-222.0 |
| 218.0 to 222.0 nm | 14000-18000 |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿1,280.00 |
+
-
|
| 0.005 | 10-20 days | ฿5,190.00 |
+
-
|
Digitoxigenin
Digitoxigenin is primarily used in the field of pharmacology and medical research due to its role as a precursor in the synthesis of cardiac glycosides, such as digoxin and digitoxin. These compounds are crucial in the treatment of various heart conditions, including atrial fibrillation, atrial flutter, and heart failure. Digitoxigenin itself exhibits cardiotonic properties, which help in enhancing the force of heart contractions and improving cardiac output. Additionally, it is employed in biochemical studies to investigate the mechanisms of action of cardiac glycosides and their effects on sodium-potassium ATPase activity. Its application extends to the development of new therapeutic agents targeting cardiovascular diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :